Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
about
Daphnoretin, a new protein kinase C activator isolated from Wikstroemia indica C.A. MeyAspirin, haemostasis and thrombosis.Professor Bamford's research in the field of biomaterials.Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (furadantin).Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.Persistence of increased platelet cyclic AMP induced by prostaglandin E1 after removal of the hormone.5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache.13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.Cyclic 3',5'-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic amp in platelet function.Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.Abnormal platelet function in Chediak-Higashi syndrome.Effects of collagen and of aspirin on the concentration of guanosine 3':5'-cyclic monophosphate in human blood platelets: measurement by a prelabelling technique.Regulation of platelet glycoprotein IIb/IIIa (integrin alpha IIB beta 3) function via the thrombin receptor.The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.Effects of catecholamines on the formation of adenosine 3':5'-cyclic monophosphate in human blood platelets.Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.Cyclic AMP of blood platelets: accumulation in organelles storing 5-hydroxytryptamine and ATP.Positive interaction between agonists in the aggregation response of human blood platelets: interation between ADP, adrenaline and vasopressin.
P2860
Q24528164-63B8DA32-E073-4F28-96C2-DD6370135CBFQ34064713-C97A1C2D-C402-45CC-A7E0-408E2C95B074Q34191673-E65235E7-9975-4CC5-8949-8B6DB8F266CEQ34510988-1C2D48F1-5C93-4878-B2A2-1400A80A3FA4Q35898543-3FD0D4BE-0BFC-43E8-832A-860F23C80A9CQ36390598-D85833E8-6DAF-47C3-8DD2-286662E2FF22Q37085513-C52F984A-7528-496C-B0D2-A459FAE9DA28Q37341093-80B011B9-6ABF-4E31-965C-A717EBB3570CQ39897069-869E310D-6176-40E4-9161-9B1724A0D64AQ39963342-5BDDB9E1-B308-4EFA-98F5-4518973AB9B4Q40077439-C7AC9C56-470F-4827-839D-20753FDBF4FAQ41896509-17BF9B88-5E56-46B4-8C02-467669BCD81AQ42821559-9677FBE4-FF3B-47B7-8A33-ED56E89C38B8Q42921880-9CAFB82C-E13A-42D9-A654-585144068566Q42924177-7D0FB904-0AB2-4192-B3C3-0388939A55D1Q43658089-504DB140-1709-4EFF-879D-B47147D9A1F3Q46624888-80A597DF-32D1-428A-9526-9135D4EAA3C4Q51878922-F18167FA-C79E-4BF7-8E85-087066764256
P2860
Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Effet of prostaglandin E1 alon ...... ne 3':5'-cyclic monophosphate.
@en
Effet of prostaglandin E1 alon ...... ne 3':5'-cyclic monophosphate.
@nl
type
label
Effet of prostaglandin E1 alon ...... ne 3':5'-cyclic monophosphate.
@en
Effet of prostaglandin E1 alon ...... ne 3':5'-cyclic monophosphate.
@nl
prefLabel
Effet of prostaglandin E1 alon ...... ne 3':5'-cyclic monophosphate.
@en
Effet of prostaglandin E1 alon ...... ne 3':5'-cyclic monophosphate.
@nl
P2093
P2860
P356
P1433
P1476
Effet of prostaglandin E1 alon ...... ne 3':5'-cyclic monophosphate.
@en
P2093
P2860
P304
P356
10.1042/BJ1200709
P407
P577
1970-12-01T00:00:00Z